History
  • No items yet
midpage
Inre: Steve Morsa
713 F.3d 104
| Fed. Cir. | 2013
Read the full case

Background

  • Morsa appeals a Board decision affirming rejections of numerous claims in the ’228 application.
  • The examiner relied on PMA (Peter Martin Associates) as prior art disclosing HelpWorks, Web Edition and related eligibility server concepts.
  • Morsa challenged the PMA’s publication date, enablement, and differences with his claims, and argued objective factors for nonobviousness.
  • The Board found PMA anticipatory for claims 271-272 and sustained obviousness rejections for many other claims.
  • The Board granted rehearing partially, then denied further rehearing; the court vacates as to 271-272 enablement and remands, while affirming obviousness with respect to other claims.
  • On review, the court affirms the Board’s factual findings, vacates the anticipation ruling for 271-272, and remands those claims for proper enablement analysis.

Issues

Issue Plaintiff's Argument Defendant's Argument Held
Whether PMA anticipates claims 271-272 Morsa argues PMA is not enabling and dates are unreliable Board reasoned PMA predated and is enabling, supporting anticipation Anticipation vacated; enablement remand required
Whether the remaining claims are obvious over PMA Differences are nonobvious and objective factors support nonobviousness PM A teaches screening, data storage, and web-based benefit matching making claims obvious Claims found obvious; affirmed for those claims
Whether the Board properly weighed enablement and anticipation under Antor Amgen framework Antor requires thorough review; PMA may not be enabling on its face and date disputed Prior art presumed enabling and Board followed appropriate precedent Enablement analysis inadequate; remand on 271-272

Key Cases Cited

  • In re Antor Media Corp., 689 F.3d 1282 (Fed. Cir. 2012) (presumption of enablement for prior art; burden shifts to challenge enablement)
  • Amgen, Inc. v. Hoechst Marion Roussel, Inc., 314 F.3d 1313 (Fed. Cir. 2003) (prior art cited as enabling; burden on patentee to rebut)
  • In re Gleave, 560 F.3d 1331 (Fed. Cir. 2009) (anticipation reviewed with substantial evidence)
  • In re Ngai, 367 F.3d 1336 (Fed. Cir. 2004) (alternative grounds for obviousness and non-obviousness considerations)
  • Graham v. John Deere Co., 383 U.S. 1 (U.S. 1966) (framework for evaluating obviousness)
  • In re Sernaker, 702 F.2d 989 (Fed. Cir. 1983) (requirement to consider objective factors in obviousness)
  • In re Cyclobenzaprine Hydrochloride Extended-Release Capsule Patent Litig., 676 F.3d 1063 (Fed. Cir. 2012) (objective considerations in obviousness analysis)
  • In re Jolley, 308 F.3d 1317 (Fed. Cir. 2002) (substantial evidence standard and determinations on factual findings)
Read the full case

Case Details

Case Name: Inre: Steve Morsa
Court Name: Court of Appeals for the Federal Circuit
Date Published: Apr 5, 2013
Citation: 713 F.3d 104
Docket Number: 2012-1609
Court Abbreviation: Fed. Cir.